Evidence map›Paper›PMID 28801462›Full record

ArticleThe Journal of biological chemistry2017

Protein glutaminylation is a yeast-specific posttranslational modification of elongation factor 1A.

Thomas Jank, Yury Belyi, Christophe Wirth, Sabine Rospert, Zehan Hu, Jörn Dengjel, Tina Tzivelekidis, Gregers Rom Andersen, Carola Hunte, Andreas Schlosser and 1 more

Open access · hybridAbstract readComparative Study
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 4 countries.

Thomas JankFrom the Institute for Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany, thomas.jank@pharmakol.uni-freiburg.de.
Yury Belyithe Gamaleya Research Centre, Moscow 123098, Russia.
Christophe Wirththe Institute for Biochemistry and Molecular Biology, ZBMZ, Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany.
Sabine Rospertthe Institute for Biochemistry and Molecular Biology, ZBMZ, Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany.
Zehan Huthe Department of Dermatology, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Jörn Dengjelthe Department of Dermatology, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Tina TzivelekidisFrom the Institute for Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany.
Gregers Rom Andersenthe Department of Molecular Biology and Genetics, Center for Structural Biology, Aarhus University, DK8000 Aarhus, Denmark, and.
Carola Huntethe Institute for Biochemistry and Molecular Biology, ZBMZ, Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany.
Andreas Schlosserthe Rudolf Virchow Center for Experimental Biomedicine, University of Würzburg, 97080 Würzburg, Germany.
Klaus AktoriesFrom the Institute for Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany, klaus.aktories@pharmakol.uni-freiburg.de.
University of Freiburg · DEAarhus University · DKGamalei Institute of Epidemiology and Microbiology · RUUniversity of Fribourg · CHUniversity of Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ribosomal translation factors are fundamental for protein synthesis and highly conserved in all kingdoms of life. The essential eukaryotic elongation factor 1A (eEF1A) delivers aminoacyl tRNAs to the A-site of the translating 80S ribosome. Several studies have revealed that eEF1A is posttranslationally modified. Using MS analysis, site-directed mutagenesis, and X-ray structural data analysis of

Indexed as

Models, MolecularProtein Processing, Post-TranslationalAmino Acid SequenceAmino Acid SubstitutionAminoacylationAnti-Infective AgentsConserved SequenceCrystallography, X-RayDatabases, ProteinGene Expression Regulation, FungalGlutamic AcidGlutamineHelix-Loop-Helix MotifsMutagenesis, Site-DirectedMutationPeptide Elongation Factor 1Anti-Infective AgentsGlutamic AcidGlutaminePeptide Elongation Factor 1Recombinant Fusion ProteinsSaccharomyces cerevisiae ProteinsTEF2 protein, S cerevisiaeeukaryotic elongation factor eEF1AglutaminylationGTPasehelix A*–loop–helix A′ regionposttranslational modification (PTM)protein synthesisSaccharomyces cerevisiaeSchizosaccharomyces pombeswitch I regiontranslation elongation factor

Identifiers

PMID28801462
PMCPMC5625034
OpenAlexW2743264882

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.